A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published in Neurology.
This article was originally published on MedicalXpress.com
GLP-1 diabetes drugs linked to lower epilepsy risk in large study
You may also be interested in:
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
The Latest
Twelve Foot Massage Techniques To Try Today
In this article, we will introduce you to 12 incredibly effective foot massage techniques that will leave you feeling rejuvenated and relaxed. Foot massages aren’t just a luxury; they provide numerous health benefits, such as […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Read More:
-
As measles outbreaks spread across the United States, a top Trump administration health official is urging families to protect themselves by getting vaccinated.This article was [...]
-
A new study led by researchers at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania School of Medicine (Penn Medicine) has identified which [...]
-
Maternal diabetes (type 1 diabetes mellitus [T1DM], type 2 diabetes mellitus [T2DM], and gestational diabetes mellitus [GDM]) is associated with an increased risk for epilepsy [...]
